Versor Investments LP Buys Shares of 12,300 Enhabit, Inc. (NYSE:EHAB)

Versor Investments LP purchased a new position in Enhabit, Inc. (NYSE:EHAB) in the third quarter, HoldingsChannel.com reports. The firm purchased 12,300 shares of the company’s stock, valued at approximately $97,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. AREX Capital Management LP increased its position in Enhabit by 2.5% in the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock worth $22,056,000 after buying an additional 59,353 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Enhabit by 1.5% in the second quarter. Dimensional Fund Advisors LP now owns 1,756,745 shares of the company’s stock worth $15,669,000 after buying an additional 26,753 shares in the last quarter. Paradice Investment Management LLC increased its position in Enhabit by 0.7% in the second quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company’s stock worth $13,603,000 after buying an additional 11,128 shares in the last quarter. DekaBank Deutsche Girozentrale increased its position in Enhabit by 52.3% in the second quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock worth $4,306,000 after buying an additional 178,000 shares in the last quarter. Finally, Kent Lake Capital LLC purchased a new stake in Enhabit in the first quarter worth about $5,183,000.

Enhabit Stock Performance

NYSE:EHAB opened at $7.35 on Monday. The company has a current ratio of 1.46, a quick ratio of 1.48 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $11.74. The stock has a 50-day moving average price of $7.56 and a 200 day moving average price of $8.47. The stock has a market capitalization of $369.56 million, a P/E ratio of -3.17 and a beta of 1.84.

Enhabit (NYSE:EHAB) last released its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The business had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. During the same quarter in the prior year, the business posted $0.03 EPS. Equities research analysts forecast that Enhabit, Inc. will post 0.25 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Jeffrey Bolton purchased 5,000 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was acquired at an average price of $8.01 per share, for a total transaction of $40,050.00. Following the acquisition, the director now directly owns 78,877 shares of the company’s stock, valued at $631,804.77. This represents a 6.77 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.90% of the stock is currently owned by company insiders.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.